Alkira Bio
PrivateLast Round
Seed
Jul 8, 2024
Total Funding Raised
$865,000
Company Overview
Alkira Bio operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Seed round in July 2024.
Alkira Bio is a biotechnology company that develops therapeutic antibodies targeting complex membrane proteins, including G protein-coupled receptors (GPCRs), using its proprietary LASEREDD technology platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alkira Bio Comparables
Compare Alkira Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbTherx, Inc. | 75% | |
| Antiverse | 74% | |
| Confo Therapeutics | 73% |
For institutional investors. Book with your work email.
Alkira Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 8, 2024 | ||||
| Accelerator | Jul 25, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alkira Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Accelerator |
| Jumar Bioincubator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2024
Seed round led by Curie.Bio
- Jul 25, 2022
$865K round led by CUREator and Jumar Bioincubator
For institutional investors. Book with your work email.
Alkira Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alkira Bio's valuation, stock price, and market status.
Is Alkira Bio a public or private company?
Alkira Bio is a private company.
What is the current stock price of Alkira Bio?
Alkira Bio is a private company, so its shares have no public market price. Caplight tracks Alkira Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alkira Bio worth (valuation)?
Valuation information for Alkira Bio is not publicly available.
Can I buy Alkira Bio stock?
Alkira Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alkira Bio's last funding round?
Alkira Bio's most recent funding round was Seed on July 8, 2024.
Who are the main investors in Alkira Bio?
Key investors in Alkira Bio include CUREator.
Will Alkira Bio IPO soon?
No public IPO plans have been announced for Alkira Bio.
How can I track Alkira Bio secondary market activity?
Caplight tracks bids, offers, and trades in Alkira Bio's shares on secondary markets.